Mountain View, CA, March 11, 2003
IMPAC Medical Systems, Inc. (NASDAQ:IMPC), a leading
provider of information technology solutions for cancer care,
today announced the signing of an OpenRTTM certification agreement
with Royal Philips Electronics (NYSE: PHG; AEX: PHI). The OpenRT
certification program was developed by IMPAC to forward strong
working relationships with radiotherapy treatment planning
vendors. IMPAC currently has signed agreements with NOMOS Corp.,
Computerized Medical Systems, Inc., and Philips.
OpenRT Certification establishes compliance, validation,
deployment, and support standards for the interoperability of
treatment planning systems with IMPAC’s Electronic Medical Record
(EMR) in preparation for treatment delivery. “Providing reliable
and predictable information transfer between medical devices
requires collaboration beyond DICOM compliance. The OpenRT program
showcases our commitment to continual improvement of both the
interfaces themselves and the systems in place to support our
customers who use them,” said Annette Coleman, market manager at
IMPAC.
Joe Jachinowski, president and CEO of IMPAC added, “IMPAC
initiated the OpenRT program to improve the interoperability and
support of a multi-component, multi-vendor system. The combination
of IMPAC’s DICOM communications product line with Philips’
Pinnacle3® treatment planning system provides integrated tools to
improve overall process efficiency and quality of care.”
Ian Farmer, vice president and general manager of Radiation
Oncology Systems, Philips Medical Systems concurred, saying, “We
are very pleased to be working with the leading provider of
Oncology Information Systems to ensure that DICOM interoperability
between our products is seamless and efficient. We believe this
agreement will significantly enhance our mutual customers’
satisfaction with inter-product workflow and after sales support.”
About IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc. is a leading provider of specialized
IT solutions that streamline both clinical and business operations
to help improve the process of delivering quality patient care.
With open integration to multiple healthcare data and imaging
systems, IMPAC offers a comprehensive IT solution that includes
specialized electronic charting, full-featured practice
management, clinical laboratory management, and outcomes
reporting. Supporting over 1500 installations worldwide, IMPAC
delivers practical solutions that deliver better overall
communication, process efficiency and quality patient care. For
more information about IMPAC Medical Systems’ products and
services, please call 650-623-8800 or visit
www.impac.com.
About Royal Philips Electronics:
Royal Philips Electronics of the Netherlands is one of the world's
biggest electronics companies and Europe's largest, with sales of
$30.1 billion (EUR 31.8 billion) in 2002. It is a global leader in
color television sets, lighting, electric shavers, medical
diagnostic imaging and patient monitoring, and one-chip TV
products. Its 170,000 employees in more than 60 countries are
active in the areas of lighting, consumer electronics, domestic
appliances, components, semiconductors, and medical systems.
Philips is quoted on the NYSE (symbol: PHG), London, Frankfurt,
Amsterdam and other stock exchanges. News from Philips is located
at www.philips.com/newscenter/usa/. For additional information
about Philips medical products and services, please contact Heidi
Wilson at 978-659-7302 or
heidi.wilson@philips.com.
The statements contained in this press release that are not purely
historical are forward looking statements within the meaning of
Section 21E of the Securities and Exchange Act of 1934, including
statements regarding the Company's expectations, beliefs, hopes,
intentions or strategies regarding the future. Forward looking
statements include statements regarding the Company's business
strategy, timing of, and plans for, the introduction of new
products and enhancements, future sales, market growth and
direction, competition, market share, revenue growth, operating
margins and profitability. All forward looking statements included
in this document are based upon information available to the
Company as of the date hereof, and the Company assumes no
obligation to update any such forward looking statement. Actual
results could differ materially from the Company's current
expectations. Factors that could cause or contribute to such
differences include the Company's ability to expand outside the
radiation oncology market or expand into international markets,
integrate its products successfully with related products and
systems in the medical services industry, reliance on distributors
and manufacturers of oncology equipment to market its products,
and other factors and risks discussed in the Company's Final
Prospectus dated November 20, 2002 and other reports filed by the
Company from time to time with the Securities and Exchange
Commission. |
|
Michelle Arnold
Public Relations Manager
IMPAC Medical Systems, Inc.
650-623-8883
pr@impac.com
Link Disclaimer
|
